Diabetic kidney disease (DKD) is an important consideration for healthcare professionals supporting people with type 2 diabetes in primary care. An annual clinical review provides a critical opportunity for DKD screening and monitoring, using estimated glomerular filtration rate (eGFR) and urine albumin:creatinine ratio (UACR) to gain an understanding of an individual’s level of adverse risk. This article aims to improve understanding of DKD and its impact, as well as the importance of screening for early identification. Key aspects of national and international clinical guidelines are explained, and useful resources are signposted. A quick-reference DKD Screening/Monitoring Tool has also been provided within the supplementary material to guide and support appropriate and timely DKD testing for all individuals with type 2 diabetes.